TransThera Sciences Included as Constituent of Hang Seng Index Series

MT Newswires Live03-09

TransThera Sciences (HKG:2617) will be included as a constituent of the Hang Seng Index Series effective Monday, March 9, according to a same-day Hong Kong bourse filing.

The clinical-stage biopharmaceutical firm has been deleted from the Hang Seng Composite SmallCap Index effective the same day.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment